Board meeting to approve September 2026 results

Results View source PDF Explain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.9%Reaction day

₹2784.00

prior close

₹2754.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%-3.6% vs market

Pharmaceuticals peers, median of 170sector-1.5%-4.3% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 4.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.7

15m

-0.3

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.9-2.3-3.6-1.5-4.3

Next day

-0.1-1.9+1.9-0.5+0.4

+2.3-0.2+2.6+1.5+0.8

+2.5pendingpending+2.5+0.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on October 29, 2026, to approve unaudited company-only and combined financial results for the quarter and six months ended September 30, 2026. The report will also include a limited review. Trading by designated persons and their relatives remains closed from October 1 until 48 hours after the results are published.

Likely market impact

No financial figures or outlook were disclosed. Shareholders may see stock volatility around the October 29 results announcement.